Tazeen Ahmad
Stock Analyst at Bank of America Securities
(4.05)
# 1,736
Out of 5,128 analysts
1110
Total ratings
55.1%
Success rate
3.8%
Average return
Main Sectors:
Stocks Rated by Tazeen Ahmad
| Stock | Action | Price Target | Current | Upside | Ratings | Updated | |
|---|---|---|---|---|---|---|---|
| VRTX Vertex Pharmaceuticals | Maintained: Buy | n/a | $547.89 | - | 34 | Nov 12, 2026 | |
| REGN Regeneron Pharmaceuticals | Maintained: Buy | $1,030 | $916.06 | +12.44% | 17 | Nov 11, 2026 | |
| ACAD Acadia Pharmaceuticals | Maintained: Buy | $31 | $18.28 | +69.58% | 52 | Nov 11, 2026 | |
| PEPG PepGen | Upgraded: Hold | $2.5 → $6 | $4.61 | +30.15% | 23 | Nov 10, 2026 | |
| ANNX Annexon | Reiterated: Buy | $8 | $4.21 | +90.02% | 26 | Nov 9, 2026 | |
| BCAX Bicara Therapeutics | Reiterated: Buy | $34 | $10.18 | +233.99% | 8 | Nov 9, 2026 | |
| DFTX Definium Therapeutics | Reiterated: Buy | $91 | $34.64 | +162.70% | 4 | Nov 9, 2026 | |
| OCUL Ocular Therapeutix | Reiterated: Buy | $27 | $6.61 | +308.47% | 25 | Nov 9, 2026 | |
| ARVN Arvinas | Reiterated: Hold | $16 → $15 | $6.92 | +116.76% | 25 | Nov 6, 2026 | |
| FATE Fate Therapeutics | Reiterated: Hold | $2.2 → $2.5 | $1.77 | +41.24% | 13 | Nov 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $8 | $8.56 | -6.54% | 18 | Nov 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $16.42 | - | 74 | Nov 6, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $151.64 | - | 54 | Nov 5, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $328 → $347 | $465.23 | -25.41% | 11 | Nov 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $19.85 | - | 23 | Nov 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $20 | $16.14 | +23.92% | 54 | Nov 4, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $114 → $108 | $87.21 | +23.84% | 59 | Nov 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $169.14 | - | 50 | Nov 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $150 | $113.95 | +31.64% | 46 | Nov 3, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $140 → $143 | $120.30 | +18.87% | 59 | Nov 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $64.14 | - | 54 | Oct 30, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $1,157 | $971.55 | +19.09% | 73 | Oct 28, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $45 | $30.02 | +49.90% | 4 | Oct 26, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $1.5 | $1.37 | +9.49% | 4 | Oct 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Upgraded: Buy | $44 | $33.99 | +29.45% | 22 | Oct 23, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $168 → $172 | $170.87 | +0.66% | 13 | Oct 20, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $48.00 | - | 13 | Oct 16, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $256.59 | - | 75 | Oct 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $15 | $7.53 | +99.20% | 37 | Oct 9, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $30 | $8.35 | +259.28% | 3 | Sep 29, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $123 → $144 | $136.64 | +5.39% | 18 | Sep 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $200 | $156.52 | +27.78% | 6 | Sep 2, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $28.61 | - | 3 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | n/a | $10.17 | - | 14 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | n/a | $4.28 | - | 7 | Aug 14, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $3 | $3.72 | -19.35% | 24 | Aug 7, 2026 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $1 | $0.4666 | n/a | 1 | Apr 1, 2025 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $82 → $79 | $12.46 | n/a | 12 | Sep 19, 2024 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $2 → $1 | $1.51 | n/a | 8 | Oct 17, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $7 → $0.5 | $13.74 | n/a | 7 | Aug 11, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4 | $1.63 | n/a | 3 | May 24, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $6 | $3.76 | n/a | 7 | Mar 27, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $4.5 → $23 | $337.59 | n/a | 4 | Mar 6, 2023 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $5 → $1 | $32.64 | n/a | 3 | Nov 16, 2022 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $16 → $8 | $0.171 | n/a | 6 | Jul 21, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $150 | $250.83 | n/a | 1 | Jan 25, 2021 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $26 | $2.53 | n/a | 1 | Mar 4, 2019 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $8 | $11.51 | n/a | 1 | Dec 20, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Hold | $46 → $48 | $36.49 | n/a | 3 | Oct 10, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $41 → $6 | $1.56 | n/a | 2 | Aug 3, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Buy | $23 | $3.00 | n/a | 1 | Feb 20, 2018 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Initiated Coverage: Hold | $16 | $1.01 | n/a | 1 | Nov 27, 2017 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $5 | $7.31 | n/a | 1 | Nov 8, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Sell | $5 | $73.35 | n/a | 1 | Jun 2, 2016 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Downgraded: Sell | $13 | $19.08 | n/a | 1 | Sep 9, 2015 | |
| XXXX XXXXXXXXXXXXXXXX Upgrade | Reiterated: Buy | $110 | $43.50 | n/a | 1 | Sep 19, 2014 |
Vertex Pharmaceuticals
Nov 12, 2026
Maintained: Buy
Price Target: n/a
Current: $547.89
Upside: -
Regeneron Pharmaceuticals
Nov 11, 2026
Maintained: Buy
Price Target: $1,030
Current: $916.06
Upside: +12.44%
Acadia Pharmaceuticals
Nov 11, 2026
Maintained: Buy
Price Target: $31
Current: $18.28
Upside: +69.58%
PepGen
Nov 10, 2026
Upgraded: Hold
Price Target: $2.5 → $6
Current: $4.61
Upside: +30.15%
Annexon
Nov 9, 2026
Reiterated: Buy
Price Target: $8
Current: $4.21
Upside: +90.02%
Bicara Therapeutics
Nov 9, 2026
Reiterated: Buy
Price Target: $34
Current: $10.18
Upside: +233.99%
Definium Therapeutics
Nov 9, 2026
Reiterated: Buy
Price Target: $91
Current: $34.64
Upside: +162.70%
Ocular Therapeutix
Nov 9, 2026
Reiterated: Buy
Price Target: $27
Current: $6.61
Upside: +308.47%
Arvinas
Nov 6, 2026
Reiterated: Hold
Price Target: $16 → $15
Current: $6.92
Upside: +116.76%
Fate Therapeutics
Nov 6, 2026
Reiterated: Hold
Price Target: $2.2 → $2.5
Current: $1.77
Upside: +41.24%
Nov 6, 2026
Reiterated: Sell
Price Target: $8
Current: $8.56
Upside: -6.54%
Nov 6, 2026
Reiterated: Sell
Price Target: n/a
Current: $16.42
Upside: -
Nov 5, 2026
Reiterated: Buy
Price Target: n/a
Current: $151.64
Upside: -
Nov 4, 2026
Reiterated: Sell
Price Target: $328 → $347
Current: $465.23
Upside: -25.41%
Nov 4, 2026
Reiterated: Buy
Price Target: n/a
Current: $19.85
Upside: -
Nov 4, 2026
Reiterated: Hold
Price Target: $20
Current: $16.14
Upside: +23.92%
Nov 3, 2026
Reiterated: Buy
Price Target: $114 → $108
Current: $87.21
Upside: +23.84%
Nov 3, 2026
Reiterated: Buy
Price Target: n/a
Current: $169.14
Upside: -
Nov 3, 2026
Reiterated: Buy
Price Target: $150
Current: $113.95
Upside: +31.64%
Nov 2, 2026
Reiterated: Buy
Price Target: $140 → $143
Current: $120.30
Upside: +18.87%
Oct 30, 2026
Reiterated: Buy
Price Target: n/a
Current: $64.14
Upside: -
Oct 28, 2026
Reiterated: Buy
Price Target: $1,157
Current: $971.55
Upside: +19.09%
Oct 26, 2026
Reiterated: Buy
Price Target: $45
Current: $30.02
Upside: +49.90%
Oct 23, 2026
Reiterated: Sell
Price Target: $1.5
Current: $1.37
Upside: +9.49%
Oct 23, 2026
Upgraded: Buy
Price Target: $44
Current: $33.99
Upside: +29.45%
Oct 20, 2026
Reiterated: Buy
Price Target: $168 → $172
Current: $170.87
Upside: +0.66%
Oct 16, 2026
Reiterated: Buy
Price Target: n/a
Current: $48.00
Upside: -
Oct 9, 2026
Reiterated: Buy
Price Target: n/a
Current: $256.59
Upside: -
Oct 9, 2026
Reiterated: Buy
Price Target: $15
Current: $7.53
Upside: +99.20%
Sep 29, 2026
Reiterated: Buy
Price Target: $30
Current: $8.35
Upside: +259.28%
Sep 14, 2026
Reiterated: Buy
Price Target: $123 → $144
Current: $136.64
Upside: +5.39%
Sep 2, 2026
Reiterated: Buy
Price Target: $200
Current: $156.52
Upside: +27.78%
Aug 14, 2026
Reiterated: Buy
Price Target: n/a
Current: $28.61
Upside: -
Aug 14, 2026
Reiterated: Sell
Price Target: n/a
Current: $10.17
Upside: -
Aug 14, 2026
Reiterated: Buy
Price Target: n/a
Current: $4.28
Upside: -
Aug 7, 2026
Reiterated: Sell
Price Target: $3
Current: $3.72
Upside: -19.35%
Apr 1, 2025
Downgraded: Sell
Price Target: $1
Current: $0.4666
Upside: n/a
Sep 19, 2024
Reiterated: Buy
Price Target: $82 → $79
Current: $12.46
Upside: n/a
Oct 17, 2023
Reiterated: Sell
Price Target: $2 → $1
Current: $1.51
Upside: n/a
Aug 11, 2023
Downgraded: Sell
Price Target: $7 → $0.5
Current: $13.74
Upside: n/a
May 24, 2023
Reiterated: Hold
Price Target: $4
Current: $1.63
Upside: n/a
Mar 27, 2023
Reiterated: Sell
Price Target: $6
Current: $3.76
Upside: n/a
Mar 6, 2023
Reiterated: Hold
Price Target: $4.5 → $23
Current: $337.59
Upside: n/a
Nov 16, 2022
Downgraded: Sell
Price Target: $5 → $1
Current: $32.64
Upside: n/a
Jul 21, 2021
Reiterated: Buy
Price Target: $16 → $8
Current: $0.171
Upside: n/a
Jan 25, 2021
Reiterated: Hold
Price Target: $150
Current: $250.83
Upside: n/a
Mar 4, 2019
Initiated Coverage: Buy
Price Target: $26
Current: $2.53
Upside: n/a
Dec 20, 2018
Downgraded: Sell
Price Target: $8
Current: $11.51
Upside: n/a
Oct 10, 2018
Reiterated: Hold
Price Target: $46 → $48
Current: $36.49
Upside: n/a
Aug 3, 2018
Downgraded: Sell
Price Target: $41 → $6
Current: $1.56
Upside: n/a
Feb 20, 2018
Initiated Coverage: Buy
Price Target: $23
Current: $3.00
Upside: n/a
Nov 27, 2017
Initiated Coverage: Hold
Price Target: $16
Current: $1.01
Upside: n/a
Nov 8, 2016
Reiterated: Sell
Price Target: $5
Current: $7.31
Upside: n/a
Jun 2, 2016
Reiterated: Sell
Price Target: $5
Current: $73.35
Upside: n/a
Sep 9, 2015
Downgraded: Sell
Price Target: $13
Current: $19.08
Upside: n/a
Sep 19, 2014
Reiterated: Buy
Price Target: $110
Current: $43.50
Upside: n/a